[CHEMOTHERAPY IN TREATMENT OF CARCINOMA OF THE OVARY].
D000970:Antineoplastic Agents; D001388:Aziridines; D003520:Cyclophosphamide; D004358:Drug Therapy; D005260:Female; D005472:Fluorouracil; D006801:Humans; D016685:Mitomycin; D008937:Mitomycins; D010051:Ovarian Neoplasms; D010166:Palliative Care; D013514:Surgical Procedures, Operative; D014116:Toxicology; D014228:Triaziquone; D014747:Vinblastine
D000970:Antineoplastic Agents; D001388:Aziridines; D008937:Mitomycins; D016685:Mitomycin; D014747:Vinblastine; D003520:Cyclophosphamide; C026480:inproquone; D014228:Triaziquone; D005472:Fluorouracil
ANTINEOPLASTIC AGENTS; BAYER E39; CYCLOPHOSPHAMIDE; DRUG THERAPY; FLUOROURACIL; MITOMYCIN; OVARIAN NEOPLASMS; PALLIATIVE TREATMENT; SURGERY, OPERATIVE; TOXICOLOGIC REPORT; TRIAZIQUONE; VINBLASTINE
LA CHEMIOTERAPIA NEL TRATTAMENTO DEL CARCINOMA DELL'OVAIO.